JP2013533868A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533868A5
JP2013533868A5 JP2013517018A JP2013517018A JP2013533868A5 JP 2013533868 A5 JP2013533868 A5 JP 2013533868A5 JP 2013517018 A JP2013517018 A JP 2013517018A JP 2013517018 A JP2013517018 A JP 2013517018A JP 2013533868 A5 JP2013533868 A5 JP 2013533868A5
Authority
JP
Japan
Prior art keywords
diazaspiro
pyrrolo
pyrimidin
nonan
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013533868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2011/000080 external-priority patent/WO2012003829A1/en
Publication of JP2013533868A publication Critical patent/JP2013533868A/ja
Publication of JP2013533868A5 publication Critical patent/JP2013533868A5/ja
Pending legal-status Critical Current

Links

JP2013517018A 2010-07-09 2011-07-08 タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用 Pending JP2013533868A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36309510P 2010-07-09 2010-07-09
US61/363,095 2010-07-09
PCT/DK2011/000080 WO2012003829A1 (en) 2010-07-09 2011-07-08 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof

Publications (2)

Publication Number Publication Date
JP2013533868A JP2013533868A (ja) 2013-08-29
JP2013533868A5 true JP2013533868A5 (enExample) 2014-08-28

Family

ID=44513700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517018A Pending JP2013533868A (ja) 2010-07-09 2011-07-08 タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用

Country Status (7)

Country Link
US (1) US9586961B2 (enExample)
EP (1) EP2590981B1 (enExample)
JP (1) JP2013533868A (enExample)
CN (1) CN102985425A (enExample)
RU (1) RU2013105450A (enExample)
TW (1) TW201204732A (enExample)
WO (1) WO2012003829A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104072499A (zh) * 2013-03-29 2014-10-01 黄传满 哌嗪取代嘧啶类化合物及其用途
CN103242321A (zh) * 2013-05-21 2013-08-14 苏州科捷生物医药有限公司 苄基哌嗪类化合物及其抗肿瘤用途
CN103396414B (zh) * 2013-07-16 2015-06-03 浙江医药高等专科学校 咪唑取代的噻唑并环己烷类化合物、及其抗肿瘤用途
ES2871524T3 (es) * 2013-12-05 2021-10-29 Pfizer Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas
AR101214A1 (es) * 2014-07-22 2016-11-30 Bayer Cropscience Ag Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas
CN105712998B (zh) * 2014-12-05 2019-12-13 上海润诺生物科技有限公司 氮杂吲哚类衍生物、其制备方法及其在医药上的应用
AU2017326487B2 (en) * 2016-09-14 2021-08-05 Janssen Pharmaceutica Nv Spiro bicyclic inhibitors of menin-MLL interaction
JP7101685B2 (ja) * 2017-01-20 2022-07-15 レオ ファーマ アクティーゼルスカブ 新規jakキナーゼ阻害剤としての二環式アミン
EP3576743B1 (en) * 2017-02-03 2023-01-18 LEO Pharma A/S 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors
CN108069986B (zh) * 2017-12-08 2018-10-02 牡丹江医学院 一种治疗角膜炎的活性药物及其制备方法
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
MX2022002646A (es) 2019-09-05 2022-04-26 Incyte Corp Formulacion de ruxolitinib para la reduccion de comezon en dermatitis atopica.
US11992490B2 (en) 2019-10-16 2024-05-28 Incyte Corporation Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
TW202525813A (zh) 2019-12-19 2025-07-01 比利時商健生藥品公司 經取代之直鏈螺環接衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
EA005852B1 (ru) * 1998-06-19 2005-06-30 Пфайзер Продактс Инк. ПИРРОЛО[2,3-d]ПИРИМИДИНЫ
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
SI2049529T1 (sl) 2006-07-14 2010-11-30 Merck Sharp & Dohme Substituiran diazepan oreksin receptor antagonist
KR20100015353A (ko) * 2007-04-02 2010-02-12 팔라우 파르마 에스에이 Jak3 억제제로서의 피롤로피리미딘 유도체
WO2009017838A2 (en) 2007-08-01 2009-02-05 Exelixis, Inc. Combinations of jak-2 inhibitors and other agents
DK2188289T3 (en) * 2007-08-08 2016-01-25 Lexicon Pharmaceuticals Inc (7H-Pyrrolo [2,3-D] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
JP5323095B2 (ja) 2008-02-06 2013-10-23 ノバルティス アーゲー ピロロ[2,3−d]ピリミジンおよびそのチロシンキナーゼ阻害剤としての使用
BRPI0910668A2 (pt) 2008-04-22 2019-09-24 Portola Pharmaceutiacals Inc inibidores de proteína quinases

Similar Documents

Publication Publication Date Title
JP2013533868A5 (enExample)
RU2013105450A (ru) Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение
JP5918217B2 (ja) 特定のアミノピリダジン、その組成物、及びこれらの使用方法
JP2010533158A5 (enExample)
AU2015236428B2 (en) TrkA kinase inhibitors, compositions and methods thereof
JP4638355B2 (ja) チアゾール誘導体
US9493446B2 (en) Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
JP5412429B2 (ja) 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物
AU2012221828B2 (en) Imidazo[5,1-f][1,2,4]triazines for treatment of neurological disorders
JP2016523911A5 (enExample)
JP2011503166A5 (enExample)
JP2019530695A5 (enExample)
WO2012129258A1 (en) Amidopyrazole inhibitors of interleukin receptor-associated kinases
WO2017087905A1 (en) Compound, compositions, and methods
JP2008539195A (ja) 新規のオキサジアゾール誘導体及びそれらの医学的使用
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
HRP20200440T1 (hr) 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori
CA2610888A1 (en) Inhibitors of akt activity
CA2554310A1 (en) Benzamide derivatives and their use as glucokinase activating agents
JP2012532152A5 (enExample)
JP2013523884A5 (enExample)
JP2012501312A5 (enExample)
CA2693915A1 (en) Pyrazolo[1,5-a]pyrimidine derivatives
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2014511355A5 (enExample)